Evidence map›Paper›PMID 36373669›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2022

Influence of Impurities from Manufacturing Process on the Toxicity Profile of Boron Nitride Nanotubes.

Vamsi Kodali, Keun Su Kim, Jenny R Roberts, Lauren Bowers, Michael G Wolfarth, John Hubczak, Xing Xin, Tracy Eye, Sherri Friend, Aleksandr B Stefaniak and 3 more

Open access · greenAbstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Principles of Biocompatible Nanotube Design for High-Performance Biomaterials.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Vamsi KodaliHealth Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV, 26505, USA.ORCID 0000-0001-6177-0568
Keun Su KimDivision of Emerging Technologies, National Research Council Canada, 100 Sussex Drive, Ottawa, ON, K1A 0R6, Canada.
Jenny R RobertsHealth Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV, 26505, USA.
Lauren BowersRespiratory Health Division, National Institute for Occupational Safety and Health, Morgantown, WV, 26505, USA.
Michael G WolfarthHealth Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV, 26505, USA.
John HubczakHealth Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV, 26505, USA.
Xing XinHealth Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV, 26505, USA.
Tracy EyeHealth Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV, 26505, USA.
Sherri FriendHealth Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV, 26505, USA.
Aleksandr B StefaniakRespiratory Health Division, National Institute for Occupational Safety and Health, Morgantown, WV, 26505, USA.
Stephen S LeonardHealth Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV, 26505, USA.
Michael JakubinekDivision of Emerging Technologies, National Research Council Canada, 100 Sussex Drive, Ottawa, ON, K1A 0R6, Canada.
Aaron ErdelyHealth Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV, 26505, USA.ORCID 0000-0002-2557-1673
National Institute for Occupational Safety and Health · USWest Virginia University · USNational Research Council Canada · CA

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

The toxicity of boron nitride nanotubes (BNNTs) has been the subject of conflicting reports, likely due to differences in the residuals and impurities that can make up to 30-60% of the material produced based on the manufacturing processes and purification employed. Four BNNTs manufactured by induction thermal plasma process with a gradient of BNNT purity levels achieved through sequential gas purification, water and solvent washing, allowed assessing the influence of these residuals/impurities on the toxicity profile of BNNTs. Extensive characterization including infrared and X-ray spectroscopy, thermogravimetric analysis, size, charge, surface area, and density captured the alteration in physicochemical properties as the material went through sequential purification. The material from each step is screened using acellular and in vitro assays for evaluating general toxicity, mechanisms of toxicity, and macrophage function. As the material increased in purity, there are more high-aspect-ratio particulates and a corresponding distinct increase in cytotoxicity, nuclear factor-κB transcription, and inflammasome activation. There is no alteration in macrophage function after BNNT exposure with all purity grades. The cytotoxicity and mechanism of screening clustered with the purity grade of BNNTs, illustrating that greater purity of BNNT corresponds to greater toxicity.

Indexed as

Boron CompoundsNanotubesMacrophagesBoron Compoundsboron nitrideaspect ratioboron nitride nanotubesmechanism-based screeningNALP3 inflammasomenuclear factor-κBpurityresidualstoxicity

Identifiers

PMID36373669
PMCPMC9975644
OpenAlexW4308958582

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.